Grant: Multicenter, randomized, double-blind, phase III trial to investigate the efficacy and safety of oral BIBF 1120 plus standard pemetrexed therapy compared to placebo plus standard pemetrexed therapy in patients with stage IIIB/IV or recurrent non small cell lung cancer after failure of first line chemotherapy
| Project Title |
Multicenter, randomized, double-blind, phase III trial to investigate the efficacy and safety of oral BIBF 1120 plus standard pemetrexed therapy compared to placebo plus standard pemetrexed therapy in patients with stage IIIB/IV or recurrent non small cell lung cancer after failure of first line chemotherapy
|
|---|---|
| Principal Investigator | Ho, James Chung Man (Principal investigator) |
| Co-Investigator(s) |
Dr Wang Julie Kwan Ling
(Co-Investigator)
Dr Lam David Chi Leung (Co-Investigator) Dr Wong Matthew King Yan (Co-Investigator) Dr Lam Jamie Chung Mei (Co-Investigator) |
| Funding Year |
2008/2009
|
| Amount |
328733
|
| Panel | Medicine |
| Start Date |
01-04-2009
|
| Expected Completion |
31-12-2012
|
| Status |
On-going
|
| Keywords | Stage IIIB/V or recurrent NSCLC |
| Discipline | Respiration, Cancer |
| Grant Type/Funding Scheme | Pharmaceutical Industry - General Award |
| Duration |
45
|
[Coming Soon]